These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 9922380)

  • 1. Biosynthesis and degradation of CFTR.
    Kopito RR
    Physiol Rev; 1999 Jan; 79(1 Suppl):S167-73. PubMed ID: 9922380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic approaches to repair defects in deltaF508 CFTR folding and cellular targeting.
    Powell K; Zeitlin PL
    Adv Drug Deliv Rev; 2002 Dec; 54(11):1395-408. PubMed ID: 12458151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CFTR and chaperones: processing and degradation.
    Amaral MD
    J Mol Neurosci; 2004; 23(1-2):41-8. PubMed ID: 15126691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Degradation of CFTR by the ubiquitin-proteasome pathway.
    Ward CL; Omura S; Kopito RR
    Cell; 1995 Oct; 83(1):121-7. PubMed ID: 7553863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Control of cystic fibrosis transmembrane conductance regulator membrane trafficking: not just from the endoplasmic reticulum to the Golgi.
    Farinha CM; Matos P; Amaral MD
    FEBS J; 2013 Sep; 280(18):4396-406. PubMed ID: 23773658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The human DnaJ homologue (Hdj)-1/heat-shock protein (Hsp) 40 co-chaperone is required for the in vivo stabilization of the cystic fibrosis transmembrane conductance regulator by Hsp70.
    Farinha CM; Nogueira P; Mendes F; Penque D; Amaral MD
    Biochem J; 2002 Sep; 366(Pt 3):797-806. PubMed ID: 12069690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Post-translational disruption of the delta F508 cystic fibrosis transmembrane conductance regulator (CFTR)-molecular chaperone complex with geldanamycin stabilizes delta F508 CFTR in the rabbit reticulocyte lysate.
    Fuller W; Cuthbert AW
    J Biol Chem; 2000 Dec; 275(48):37462-8. PubMed ID: 10982807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemical chaperones correct the mutant phenotype of the delta F508 cystic fibrosis transmembrane conductance regulator protein.
    Brown CR; Hong-Brown LQ; Biwersi J; Verkman AS; Welch WJ
    Cell Stress Chaperones; 1996 Jun; 1(2):117-25. PubMed ID: 9222597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rescuing cystic fibrosis transmembrane conductance regulator (CFTR)-processing mutants by transcomplementation.
    Cormet-Boyaka E; Jablonsky M; Naren AP; Jackson PL; Muccio DD; Kirk KL
    Proc Natl Acad Sci U S A; 2004 May; 101(21):8221-6. PubMed ID: 15141088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human heat shock protein 105/110 kDa (Hsp105/110) regulates biogenesis and quality control of misfolded cystic fibrosis transmembrane conductance regulator at multiple levels.
    Saxena A; Banasavadi-Siddegowda YK; Fan Y; Bhattacharya S; Roy G; Giovannucci DR; Frizzell RA; Wang X
    J Biol Chem; 2012 Jun; 287(23):19158-70. PubMed ID: 22505710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correctors promote folding of the CFTR in the endoplasmic reticulum.
    Loo TW; Bartlett MC; Clarke DM
    Biochem J; 2008 Jul; 413(1):29-36. PubMed ID: 18361776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biosynthesis of cystic fibrosis transmembrane conductance regulator.
    Pranke IM; Sermet-Gaudelus I
    Int J Biochem Cell Biol; 2014 Jul; 52():26-38. PubMed ID: 24685677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Repair of CFTR folding defects with correctors that function as pharmacological chaperones.
    Loo TW; Clarke DM
    Methods Mol Biol; 2011; 741():23-37. PubMed ID: 21594776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SERCA pump inhibitors do not correct biosynthetic arrest of deltaF508 CFTR in cystic fibrosis.
    Grubb BR; Gabriel SE; Mengos A; Gentzsch M; Randell SH; Van Heeckeren AM; Knowles MR; Drumm ML; Riordan JR; Boucher RC
    Am J Respir Cell Mol Biol; 2006 Mar; 34(3):355-63. PubMed ID: 16284361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The cystic fibrosis-causing mutation deltaF508 affects multiple steps in cystic fibrosis transmembrane conductance regulator biogenesis.
    Thibodeau PH; Richardson JM; Wang W; Millen L; Watson J; Mendoza JL; Du K; Fischman S; Senderowitz H; Lukacs GL; Kirk K; Thomas PJ
    J Biol Chem; 2010 Nov; 285(46):35825-35. PubMed ID: 20667826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of CFTR Biogenesis by the Proteostatic Network and Pharmacological Modulators.
    Estabrooks S; Brodsky JL
    Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31936842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Defects in processing and trafficking of the cystic fibrosis transmembrane conductance regulator.
    Skach WR
    Kidney Int; 2000 Mar; 57(3):825-31. PubMed ID: 10720935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural cues involved in endoplasmic reticulum degradation of G85E and G91R mutant cystic fibrosis transmembrane conductance regulator.
    Xiong X; Bragin A; Widdicombe JH; Cohn J; Skach WR
    J Clin Invest; 1997 Sep; 100(5):1079-88. PubMed ID: 9276724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chaperones rescue the energetic landscape of mutant CFTR at single molecule and in cell.
    Bagdany M; Veit G; Fukuda R; Avramescu RG; Okiyoneda T; Baaklini I; Singh J; Sovak G; Xu H; Apaja PM; Sattin S; Beitel LK; Roldan A; Colombo G; Balch W; Young JC; Lukacs GL
    Nat Commun; 2017 Aug; 8(1):398. PubMed ID: 28855508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of deltaF508 cystic fibrosis transmembrane regulator trafficking and function with 4-phenylbutyrate and flavonoids.
    Lim M; McKenzie K; Floyd AD; Kwon E; Zeitlin PL
    Am J Respir Cell Mol Biol; 2004 Sep; 31(3):351-7. PubMed ID: 15191910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.